Skip to contentC
Chemed Corp
C
CHEChemed Corp Q4 2020 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income$113.75M$113.75Mderived+73.5% vs Q4 2019 EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived$143,249,000+85.0%
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Chemed Corp · CIK 19584 · Engraved from SEC EDGAR
Operating Cash Flowderived$86,877,000+36.6% Free Cash Flowderived$70,716,000+40.5% ended Dec 31, 2020 · filed Feb 26, 2021 · 57 d after period end